The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point-Of-Care Or Rapid Diagnostics Market Research Report 2025

Global Point-Of-Care Or Rapid Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1548721

No of Pages : 116

Ask Your Query
Synopsis
Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
The global Point-Of-Care Or Rapid Diagnostics market was valued at US$ 25670 million in 2023 and is anticipated to reach US$ 48500 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
Report Scope
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Segment by Type
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Segment by Application
Hospital
Clinic
Independent Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Point-Of-Care Or Rapid Diagnostics Market Overview
1.1 Product Overview and Scope of Point-Of-Care Or Rapid Diagnostics
1.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Value Comparison by Type (2024-2030)
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Point-Of-Care Or Rapid Diagnostics Segment by Application
1.3.1 Global Point-Of-Care Or Rapid Diagnostics Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Point-Of-Care Or Rapid Diagnostics Revenue 2019-2030
1.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales 2019-2030
1.4.3 Global Point-Of-Care Or Rapid Diagnostics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Point-Of-Care Or Rapid Diagnostics Market Competition by Manufacturers
2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2019-2024)
2.4 Global Point-Of-Care Or Rapid Diagnostics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
2.7 Point-Of-Care Or Rapid Diagnostics Market Competitive Situation and Trends
2.7.1 Point-Of-Care Or Rapid Diagnostics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue
2.7.3 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario by Region
3.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Point-Of-Care Or Rapid Diagnostics Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2019-2030
3.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2019-2024
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Region: 2025-2030
3.3 Global Point-Of-Care Or Rapid Diagnostics Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2019-2030
3.3.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2019-2024
3.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region: 2025-2030
3.4 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.4.1 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
3.4.3 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.5.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
3.5.3 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.6.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
3.6.3 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.7.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
3.7.3 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2030)
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2025-2030)
4.1.3 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2019-2030)
4.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2030)
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2024)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2025-2030)
4.2.3 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2019-2030)
4.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2030)
5.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024)
5.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2025-2030)
5.1.3 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2019-2030)
5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2030)
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2024)
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2025-2030)
5.2.3 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2019-2030)
5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Corporation Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Corporation Information
6.5.2 Bio-Rad Laboratories Description and Business Overview
6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments/Updates
6.6 BioMerieux
6.6.1 BioMerieux Corporation Information
6.6.2 BioMerieux Description and Business Overview
6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.6.5 BioMerieux Recent Developments/Updates
6.7 Nova Biomedical
6.6.1 Nova Biomedical Corporation Information
6.6.2 Nova Biomedical Description and Business Overview
6.6.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.7.5 Nova Biomedical Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Quidel
6.9.1 Quidel Corporation Information
6.9.2 Quidel Description and Business Overview
6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.9.5 Quidel Recent Developments/Updates
6.10 A. Menarini Diagnostics
6.10.1 A. Menarini Diagnostics Corporation Information
6.10.2 A. Menarini Diagnostics Description and Business Overview
6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.10.5 A. Menarini Diagnostics Recent Developments/Updates
6.11 Becton Dickinson
6.11.1 Becton Dickinson Corporation Information
6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments/Updates
6.12 Biosurfit
6.12.1 Biosurfit Corporation Information
6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments/Updates
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Corporation Information
6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments/Updates
6.14 Werfen
6.14.1 Werfen Corporation Information
6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments/Updates
6.15 Abionic
6.15.1 Abionic Corporation Information
6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments/Updates
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Corporation Information
6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments/Updates
6.17 Horiba Medical
6.17.1 Horiba Medical Corporation Information
6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments/Updates
6.18 RAL
6.18.1 RAL Corporation Information
6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments/Updates
6.19 Vircell
6.19.1 Vircell Corporation Information
6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments/Updates
6.20 Monlab
6.20.1 Monlab Corporation Information
6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments/Updates
6.21 Binding Site
6.21.1 Binding Site Corporation Information
6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Point-Of-Care Or Rapid Diagnostics Industry Chain Analysis
7.2 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
7.4 Point-Of-Care Or Rapid Diagnostics Sales and Marketing
7.4.1 Point-Of-Care Or Rapid Diagnostics Sales Channels
7.4.2 Point-Of-Care Or Rapid Diagnostics Distributors
7.5 Point-Of-Care Or Rapid Diagnostics Customers
8 Point-Of-Care Or Rapid Diagnostics Market Dynamics
8.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
8.2 Point-Of-Care Or Rapid Diagnostics Market Drivers
8.3 Point-Of-Care Or Rapid Diagnostics Market Challenges
8.4 Point-Of-Care Or Rapid Diagnostics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock